ATE202561T1 - 1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit - Google Patents

1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit

Info

Publication number
ATE202561T1
ATE202561T1 AT97951323T AT97951323T ATE202561T1 AT E202561 T1 ATE202561 T1 AT E202561T1 AT 97951323 T AT97951323 T AT 97951323T AT 97951323 T AT97951323 T AT 97951323T AT E202561 T1 ATE202561 T1 AT E202561T1
Authority
AT
Austria
Prior art keywords
alkyl
alkoxy
amino
pct
group
Prior art date
Application number
AT97951323T
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE202561T1 publication Critical patent/ATE202561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT97951323T 1996-12-13 1997-12-12 1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit ATE202561T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615335A FR2757160B1 (fr) 1996-12-13 1996-12-13 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1997/002286 WO1998025903A1 (fr) 1996-12-13 1997-12-12 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
ATE202561T1 true ATE202561T1 (de) 2001-07-15

Family

ID=9498641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97951323T ATE202561T1 (de) 1996-12-13 1997-12-12 1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit

Country Status (32)

Country Link
US (1) US6034090A (de)
EP (1) EP0950048B1 (de)
JP (1) JP3881384B2 (de)
KR (1) KR100560358B1 (de)
CN (1) CN1129579C (de)
AT (1) ATE202561T1 (de)
AU (1) AU730143B2 (de)
BR (1) BR9713916A (de)
CA (1) CA2275353C (de)
CY (1) CY2274B1 (de)
CZ (1) CZ289789B6 (de)
DE (1) DE69705429T2 (de)
DK (1) DK0950048T3 (de)
EE (1) EE03763B1 (de)
ES (1) ES2160977T3 (de)
FR (1) FR2757160B1 (de)
GR (1) GR3036643T3 (de)
HK (1) HK1023997A1 (de)
HU (1) HU224347B1 (de)
IL (1) IL130003A (de)
IS (1) IS1969B (de)
NO (1) NO312720B1 (de)
NZ (1) NZ336033A (de)
PL (1) PL190789B1 (de)
PT (1) PT950048E (de)
RS (1) RS49807B (de)
RU (1) RU2189975C2 (de)
SI (1) SI0950048T1 (de)
SK (1) SK283331B6 (de)
TR (1) TR199901291T2 (de)
UA (1) UA52707C2 (de)
WO (1) WO1998025903A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
FR2832405B1 (fr) * 2001-11-19 2004-12-10 Sanofi Synthelabo Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
JP3881384B2 (ja) 2007-02-14
BR9713916A (pt) 2000-02-29
DE69705429D1 (de) 2001-08-02
PT950048E (pt) 2001-12-28
NO992869L (no) 1999-06-11
AU730143B2 (en) 2001-03-01
DK0950048T3 (da) 2001-09-24
NO992869D0 (no) 1999-06-11
HU224347B1 (hu) 2005-08-29
TR199901291T2 (xx) 1999-10-21
IL130003A (en) 2004-09-27
HUP0001185A3 (en) 2002-10-28
CZ211399A3 (cs) 2000-09-13
KR100560358B1 (ko) 2006-03-14
IL130003A0 (en) 2000-02-29
SK283331B6 (sk) 2003-06-03
CA2275353C (en) 2007-05-22
CY2274B1 (en) 2003-07-04
CN1129579C (zh) 2003-12-03
EE9900237A (et) 1999-12-15
HUP0001185A2 (hu) 2000-10-28
CZ289789B6 (cs) 2002-04-17
ES2160977T3 (es) 2001-11-16
WO1998025903A1 (fr) 1998-06-18
RU2189975C2 (ru) 2002-09-27
JP2001505902A (ja) 2001-05-08
US6034090A (en) 2000-03-07
YU24399A (sh) 2001-07-10
FR2757160A1 (fr) 1998-06-19
CA2275353A1 (en) 1998-06-18
IS1969B (is) 2004-12-15
NZ336033A (en) 2000-12-22
EP0950048A1 (de) 1999-10-20
CN1240427A (zh) 2000-01-05
KR20000069422A (ko) 2000-11-25
EE03763B1 (et) 2002-06-17
UA52707C2 (uk) 2003-01-15
RS49807B (sr) 2008-08-07
GR3036643T3 (en) 2001-12-31
NO312720B1 (no) 2002-06-24
PL190789B1 (pl) 2006-01-31
AU5489398A (en) 1998-07-03
SK78699A3 (en) 2000-01-18
IS5075A (is) 1999-06-10
FR2757160B1 (fr) 1999-03-12
DE69705429T2 (de) 2002-05-16
PL334071A1 (en) 2000-01-31
SI0950048T1 (en) 2001-10-31
EP0950048B1 (de) 2001-06-27
HK1023997A1 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
CA2225746A1 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
DE60019904D1 (de) Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
AU4437896A (en) Piperidine derivatives having tachykinin antagonist activity
ATE250590T1 (de) Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
FR2762514B1 (fr) Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
ATE202561T1 (de) 1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit
ATE290871T1 (de) Verfahren zur behandlung navikularer krankheiten bei pferden
HUP0100098A2 (hu) Hatóanyagokként, különösen tetrahidro-piridinek és acetil-kolin-észteráz gátlók kombinációját tartalmazó öregkori dementia, különösen Alzheimer típusú dementia kezelésére szolgáló gyógyszerkészítmények
IL112415A (en) 3R* 4s* -3-Ú4-(4-fluorophenyl)4-hydroxy-piperidin-1-yl¾chroman-4,7-diol and pharmaceutical compositions comprising them
PL334073A1 (en) Diphenylalkyl tetrahydropyridines, method of obtaining them and compositions containing such compounds
DK0950052T3 (da) Fremgangsmåde til fremstilling af et tetrahydropyridin-derivat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee